Acid-Suppressive Effects of Various Regimens of Omeprazole in Helicobacter pylori-Negative CYP2C19 Homozygous Extensive Metabolizers: Which Regimen Has the Strongest Effect?

被引:0
作者
Tomohiko Shimatani
Tomoko Kuroiwa
Mutsuko Moriwaki
Jing Xu
Susumu Tazuma
Masaki Inoue
机构
[1] Hiroshima University Hospital,Department of General Medicine
[2] Hiroshima University,Department of Geriatric Health Sciences, Graduate School of Health Sciences
[3] Hiroshima Prefectural Akitsu Hospital,Department of Internal Medicine
来源
Digestive Diseases and Sciences | 2007年 / 52卷
关键词
Omeprazole; CYP2C19; Homozygous extensive metabolizer; Intragastric pH; Divided dose;
D O I
暂无
中图分类号
学科分类号
摘要
To achieve more potent and long-lasting acid suppression, omeprazole was administered for 7 days in 5 regimens: 10, 20, and 40 mg once daily (od), and 10 and 20 mg twice daily (bid), in 7 healthy Helicobacter pylori-negative CYP2C19 homozygous extensive metabolizers, and intragastric pH was continuously measured. The median intragastric pH and percent time pH > 4.0 for 24 hours increased dose dependently with 10, 20, and 40 mg od. Ten and 20 mg bid wre comparable to 20 and 40 mg od, respectively. Concerning percent time pH > 4.0 in the nighttime (20:00–8:00 hours), 20 mg bid was significantly superior to 40 mg od (P < .05). In 4 of the 5 regimens, all 7 subjects had nocturnal acid breakthrough, whereas with 20 mg bid it occurred in only 3. We concluded that, considering nighttime acid suppression, omeprazole 20 mg bid had the strongest effect.
引用
收藏
页码:2826 / 2832
页数:6
相关论文
共 233 条
  • [11] Wilkinson SP(1998)Nocturnal recovery of gastric acid secretion with twice-daily dosing of proton pump inhibitors Am J Gastroenterol 93 763-767
  • [12] Foster DN(1998)Ranitidine controls nocturnal gastric acid breakthrough on omeprazole: a controlled study in normal subjects Gastroenterology 115 1335-1339
  • [13] Mountford RA(1995)Comparison of acid-inhibitory effect of omeprazole in before-breakfast dosing and after-breakfast dosing [in Japanese] Jpn Pharmacol Ther 23 879-885
  • [14] Temperley JM(1996)Optimal dosing of omeprazole 40 mg daily: effects on gastric and esophageal pH and serum gastrin in healthy controls Am J Gastroenterol 91 1532-1538
  • [15] Harvey RF(1998)Nocturnal gastric acidity and acid breakthrough on different regimens of omeprazole 40 mg daily Aliment Pharmacol Ther 12 1235-1240
  • [16] Thompson DG(2003)The efficacy of omeprazole twice daily with supplemental H2 blockade at bedtime in the suppression of nocturnal oesophageal and gastric acidity Aliment Pharmacol Ther 17 1553-1558
  • [17] Davis M(1990)Loss of acid suppression during dosing with H2-receptor antagonists Aliment Pharmacol Ther 4 15-27
  • [18] Forgacs IC(1990)Tolerance during 29 days of conventional dosing with cimetidine, nizatidine, famotidine or ranitidine Aliment Pharmacol Ther 4 29-45
  • [19] Bassett KS(1990)Tolerance during 8 days of high-dose H2-blockade: placebo-controlled studies of 24-hour acidity and gastrin Aliment Pharmacol Ther 4 47-63
  • [20] Richardson PDI(1990)The effects of 15 days of dosing with placebo, sufotidine 600 mg nocte or sufotidine 600 mg twice daily upon 24-hour intragastric acidity and 24-hour plasma gastrin Aliment Pharmacol Ther 4 65-74